Hand of the Market
Screener
Sectors
Compare
Insider buys
Funds
 Screener

ENOV Enovis CORP

Compare with sector and industry Screen the industry

Health Care · Medical Devices & Supplies · data as of 2026-10-22 · latest quarter 2026-07-03, filed 2026-08-06

Market cap
$1.24B
FCF yield
2.5%
Avg daily $ volume
$39.59M
Days to next report
14
Quality checklist

1 of 5 checks passed · quarter ending 2026-07-03

  • ROIC at least 10%-29.8%
  • Operating margin up over 3 years−39.9 pp
  • Free cash flow at least 80% of net income—
  • Share count up at most 5% in 3 years5.7%
  • Net debt at most 3× EBITDA4.1×
  • Revenue grew over 3 years12.2%
Insider buying, last 90 days
2 insiders buyingCEO bought

2 insiders bought $449,599 in 4 purchases, 2026-09-02 – 2026-09-04

  • McDonald Damien · Chief Executive Officer, director $249,620 · stake +6%
  • Engert Oliver · Chief Administrative Officer $199,979 · stake +9%
Tracked funds, latest reports
Active managers
+$17.72M +1.5 pp of the company
2 buying · 0 selling · 2 holding
Mutual funds & ETFs
+$312.05K +0.0 pp of the company
1 buying · 0 selling · 2 holding

Each factor with its sector median and, where it's reported per quarter, its last 12 quarters.

Size & liquidity
ENOVSector12 quartersMarket cap$1.24B$9.67BEnterprise value$2.52B$10.41BAvg daily $ volume$39.59M$132.68MDaily turnover3.2%1.3%
Growth
ENOVSector12 quartersRevenue CAGR 3y12.2%9.5%-18.2% → 12.2%Revenue CAGR 5y-8.1%8.9%Revenue growth YoY3.2%8.7%8.8% → 3.2%Revenue acceleration−2.2 pp+0.0 pp+0.3 pp → −2.2 ppFCF growth YoY—5.9%FCF conversion—130.8%Forward growth (HoM est.)—9.8%
Valuation
ENOVSector12 quartersP/E (trailing)—27.6×P/E (forward, HoM est.)—25.2×P/E vs. sector—1.0×PEG (HoM est.)—3.12EV/EBITDA8.2×17.5×EV/Sales1.1×3.3×FCF yield2.5%3.6%Dividend yield0.0%0.0%Shareholder yield0.0%1.2%
Quality
ENOVSector12 quartersQuality checks passed13ROIC-29.8%9.2%-1.8% → -29.8%Gross profitability37.3%32.6%21.8% → 37.3%Gross margin61.1%60.1%57.7% → 61.1%Gross margin Δ 3y+3.9 pp−0.1 pp+26.6 pp → +3.9 ppOperating margin-45.1%10.6%-5.3% → -45.1%Operating margin Δ 3y−39.9 pp+0.9 pp−3.9 pp → −39.9 ppDebt/equity0.9×0.7×0.1× → 0.9×Net debt/EBITDA4.1×2.0×3.4× → 4.1×Interest coverage-30.9×4.9×-4.1× → -30.9×Share count Δ 3y5.7%-0.3%-20.7% → 5.7%Stock compensation / revenue1.5%1.8%2.2% → 1.5%Accruals ratio-31.2%-4.3%-2.4% → -31.2%
Earnings & estimates
ENOVSector12 quartersDays to next report1413
Ownership & positioning
ENOVSector12 quartersInsider buys (90d)40Insiders buying (90d)20Insider net value (90d)$449.6K$0Institutional ownership122.1%99.6%Institutional Δ QoQ+3.9 pp+1.1 ppConviction funds net buying—−0.0 ppActive managers net buying+1.5 pp+0.1 ppActive funds net buying+0.0 pp+0.0 ppDays to cover5.754.29Short % of shares out18.3%6.0%Short interest Δ+1.9 pp+0.1 pp

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Terms of use

Source: SEC EDGAR: Forms 4 (insider trades), 10-Q and 10-K (financials). Insider trades as filed (amendments applied); financial metrics computed by Hand of the Market from the companies' quarterly and annual reports. Each trade links to its filing.

Not investment advice. These signals are starting points for research, not recommendations. Data may contain errors or lag the filings.